SPC289
Larótrectíníb og/eða lyfjafræðilega viðunandi sölt þar af, sérstaklega larótrectíníbsúlfat að meðtöldu larótrectíníbvetnissúlfati
Status:
VeittApplication date:
10.3.2020Application published:
15.4.2020Grant published:
15.3.2021
Max expiry date:
22.9.2034Medicine name:
VitrakviMedicine for children:
No
Timeline
Today
10.3.2020Application
15.4.2020Publication
15.3.2021Registration
22.9.2034Expires
Marketing license
IS authorization number:
EU/1/19/1385/001-003Date:
5.11.2019
Foreign authorization number:
EU/1/19/1385Date:
19.9.2019
Owner
Name:
Array Biopharma, Inc.Address:
3200 Walnut Street, Boulder, CO US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3106463